
Vidac Pharma Launches “TME++” Pediatric Brain Tumor Research Consortium
Vidac Pharma has announced the formation of “TME++,” a groundbreaking research consortium dedicated to advancing treatments for pediatric brain tumors. Vidac pharma Holding Plc (XSTU:SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) UNITED KINGDOM, March 24, …